Multiple inflammatory cytokines and bacterial toxins

Multiple inflammatory cytokines and bacterial toxins refers to a heterogeneous group of endogenous signaling proteins and exogenous pathogenic substances that drive systemic hyperinflammation (StatPearls, 2023). This group includes pro-inflammatory cytokines like Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha), as well as bacterial products such as lipopolysaccharides or endotoxins (PubMed, PMID: 32454104). In clinical settings like sepsis, trauma, or severe viral infections, these molecules are produced in excessive amounts, leading to a cytokine storm and subsequent organ dysfunction (Nature Reviews Nephrology, 2020). Therapeutic strategies targeting this collective group often utilize extracorporeal blood purification technologies, such as the CytoSorb device or specialized filters like oXiris, which adsorb these mediators to reduce their circulating concentrations (Annals of Intensive Care, 2023). The goal of such therapy is to modulate the immune response and prevent the progression of multi-organ failure by restoring physiological balance. However, a significant therapeutic challenge is the non-specific nature of these treatments, which may also remove beneficial substances like antibiotics or nutrients (CytoSorbents, 2024).

Other names

Inflammatory mediatorsCytokine storm mediatorsSepsis-associated toxinsPathogen-associated molecular patterns (PAMPs)Damage-associated molecular patterns (DAMPs)

Extracorporeal adsorption and neutralization of circulating inflammatory mediators and toxins to restore immune homeostasis.